Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

946
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
946
Extrinsic and Intrinsic Pathways of Hemostasis01:20

Extrinsic and Intrinsic Pathways of Hemostasis

9.4K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
9.4K
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

1.3K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.3K
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

659
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
659
Introduction to Hemostasis01:05

Introduction to Hemostasis

9.1K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
9.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effects of Immersive Virtual Reality Interventions on Symptom Management in Patients With Gastrointestinal Cancer: Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Journal of medical Internet research·2026
Same author

Frailty in older maintenance hemodialysis patients: A latent class analysis revealing personalized management.

PloS one·2026
Same author

Semantic Communication Based on Slot Attention for MIMO Transmission in 6G Smart Factories.

Sensors (Basel, Switzerland)·2026
Same author

A Fibrous-Porous Microsphere-Based Composite Filler for Synchronized Immediate and Long-Term Soft Tissue Restoration.

ACS applied materials & interfaces·2026
Same author

Acute leukemia during pregnancy: a single center experience with 23 cases, 2012-2022 and literature review.

Annals of medicine·2026
Same author

The use of virtual reality in cancer patient health education: A scoping review.

International journal of nursing sciences·2026
Same journal

High-turnover copper-catalyzed amination of aryl bromides: exploring catalyst and ligand degradation pathways.

RSC advances·2026
Same journal

Sb-based metal oxide and sulfide anode materials for alkali-ion batteries.

RSC advances·2026
Same journal

Directed evolution of a cytochrome P450 monooxygenase for improved perillyl alcohol biosynthesis <i>via</i> a tailored genetically encoded biosensor.

RSC advances·2026
Same journal

Superspin-glass dynamics and magnetic memory in ZnFe<sub>2</sub>O<sub>4</sub> nanoparticles synthesized <i>via</i> a green egg-white-assisted route.

RSC advances·2026
Same journal

Porous and luminescent Dy-doped Co-BTC MOFs for label-free detection of tetracycline and vanadium traces in water.

RSC advances·2026
Same journal

An optimized green simultaneous HPLC analysis of dissolution rate monitoring for valsartan and sacubitril in tablet medications.

RSC advances·2026
See all related articles

Related Experiment Video

Updated: Sep 24, 2025

A Facile and Efficient Approach for the Production of Reversible Disulfide Cross-linked Micelles
09:57

A Facile and Efficient Approach for the Production of Reversible Disulfide Cross-linked Micelles

Published on: December 23, 2016

9.0K

Tranexamic acid-loaded starch hemostatic microspheres.

Huantong Su1, Shuda Wei1, Fangping Chen2,3,1

  • 1Engineering Research Center for Biomedical Materials of Ministry of Education, East China University of Science and Technology Shanghai 200237 P. R. China.

RSC Advances
|May 6, 2022
PubMed
Summary
This summary is machine-generated.

New tranexamic acid-loaded cross-linked microporous starch (TACMS) offers potent hemostasis by combining physical absorption and drug-induced clot stabilization. This novel material effectively controls bleeding and improves survival rates in severe hemorrhage scenarios.

More Related Videos

TAPE: A Biodegradable Hemostatic Glue Inspired by a Ubiquitous Compound in Plants for Surgical Application
08:40

TAPE: A Biodegradable Hemostatic Glue Inspired by a Ubiquitous Compound in Plants for Surgical Application

Published on: June 8, 2016

14.3K
Author Spotlight: Advancing Therapeutics with Biocompatible Sodium Alginate Hydrogel Microspheres
07:24

Author Spotlight: Advancing Therapeutics with Biocompatible Sodium Alginate Hydrogel Microspheres

Published on: June 7, 2024

2.3K

Related Experiment Videos

Last Updated: Sep 24, 2025

A Facile and Efficient Approach for the Production of Reversible Disulfide Cross-linked Micelles
09:57

A Facile and Efficient Approach for the Production of Reversible Disulfide Cross-linked Micelles

Published on: December 23, 2016

9.0K
TAPE: A Biodegradable Hemostatic Glue Inspired by a Ubiquitous Compound in Plants for Surgical Application
08:40

TAPE: A Biodegradable Hemostatic Glue Inspired by a Ubiquitous Compound in Plants for Surgical Application

Published on: June 8, 2016

14.3K
Author Spotlight: Advancing Therapeutics with Biocompatible Sodium Alginate Hydrogel Microspheres
07:24

Author Spotlight: Advancing Therapeutics with Biocompatible Sodium Alginate Hydrogel Microspheres

Published on: June 7, 2024

2.3K

Area of Science:

  • Biomaterials Science
  • Hemostasis Research
  • Medical Device Development

Background:

  • Rapid exsanguinating hemorrhage poses a critical challenge in emergency medicine and military contexts.
  • Current hemostatic agents primarily accelerate clot formation but often neglect the crucial role of inhibiting fibrinolysis.
  • Effective hemostasis requires both rapid clot formation and stabilization to prevent re-bleeding and improve patient outcomes.

Purpose of the Study:

  • To develop and evaluate a novel drug-loaded hemostatic material combining physical properties with antifibrinolytic action.
  • To investigate the hemostatic efficacy of tranexamic acid-loaded cross-linked microporous starch (TACMS) for severe bleeding control.
  • To assess the synergistic effects of physical hemostasis and chemical antifibrinolysis in the developed material.

Main Methods:

  • Fabrication of cross-linked microporous starch (CMS) followed by loading with tranexamic acid (TA) to create TACMS.
  • Characterization of TACMS for mechanical properties, particle density, and water absorption.
  • In vitro evaluation of clotting times (PT, APTT, TT) and clot dissolution inhibition.
  • In vivo assessment of hemostatic performance in rabbit ear artery and liver injury models.

Main Results:

  • Cross-linking improved starch mechanical properties and density; TA loading did not affect water absorption.
  • TACMS significantly reduced clotting times (PT, APTT, TT) and demonstrated potent chemical hemostasis.
  • In vitro studies showed a 70% reduction in clotting time for TACMS compared to CMS, with inhibited fibrinolysis.
  • In vivo testing revealed excellent hemostatic performance in rabbit models, surpassing a commercial hemostat (Arista®).

Conclusions:

  • TACMS exhibits potent synergistic hemostatic capabilities derived from physical absorption and chemical antifibrinolysis.
  • The material demonstrates improved absorption speed, blood uptake, and mechanical strength compared to unmodified starch.
  • TACMS represents a safe and effective hemostatic system with potential for further optimization for specific injury types.